ACR适宜性标准®乳腺植入物评估:2023年更新
本文件讨论无症状和有症状乳腺植入物患者的适宜初始影像检查。无症状生理盐水植入物患者不建议影像检查;硅胶植入物术后5至6年首次超声或MRI、此后每2至3年复查一次;疑似硅胶破裂时超声或非增强MRI通常适宜;不明原因腋窝淋巴结肿大时超声和/或乳腺X线通常适宜;疑似植入物相关间变性大细胞淋巴瘤时超声通常为初始影像。
要点
- 无症状生理盐水植入物患者不建议影像检查;有破裂疑虑时超声通常适宜。
- FDA建议硅胶植入物术后5至6年首次超声或MRI,此后每2至3年复查。
- 疑似硅胶植入物破裂时,超声或非增强MRI通常适宜作为初始影像。
核心结论
- 文件针对无症状与有症状乳腺植入物患者给出初始影像选择的适宜性推荐,涵盖生理盐水与硅胶植入物、破裂疑虑、不明原因腋窝淋巴结肿大及疑似植入物相关间变性大细胞淋巴瘤等场景。
研究设计与样本
- 由美国放射学会(ACR)适宜性标准多学科专家组制定,每年审查;采用GRADE等循证方法系统分析同行评议文献,并依据RAND/UCLA适宜性方法用户手册确定影像与治疗程序的适宜性;同行评议文献缺乏或模棱两可时,专家可为主要证据来源。
诊断标准与关键数值
- 无症状生理盐水植入物患者:不建议影像检查。
- 有破裂疑虑的生理盐水植入物患者:超声通常适宜,但生理盐水破裂常临床表现明显。
- 硅胶植入物患者:FDA建议术后5至6年首次超声或MRI检查,此后每2至3年复查一次。
- 当前或既往有硅胶乳腺植入物且不明原因腋窝淋巴结肿大患者:超声和/或乳腺X线通常适宜,取决于年龄。
- 疑似硅胶植入物破裂患者:超声或非增强MRI通常适宜。
临床应用与阅片要点
- 无症状生理盐水植入物患者不安排影像检查;有破裂疑虑时可选超声。
- 硅胶植入物患者按FDA建议在术后5至6年首次超声或MRI,此后每2至3年复查一次。
- 疑似硅胶植入物破裂时选择超声或非增强MRI。
- 不明原因腋窝淋巴结肿大且有当前或既往硅胶植入物时,根据年龄选择超声和/或乳腺X线。
- 疑似植入物相关间变性大细胞淋巴瘤时以超声作为初始影像。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This document discusses the appropriate initial imaging in both asymptomatic and symptomatic patients with breast implants. For asymptomatic patients with saline implants, no imaging is recommended. If concern for rupture exists, ultrasound is usually appropriate though saline rupture is often clinically evident. The FDA recently recommended patients have an initial ultrasound or MRI examination 5 to 6 years after initial silicone implant surgery and then every 2 to 3 years thereafter. In a patient with unexplained axillary adenopathy with current or prior silicone breast implants, ultrasound and/or mammography are usually appropriate, depending on age. In a patient with concern for silicone implant rupture, ultrasound or MRI without contrast is usually appropriate. In the setting of a patient with breast implants and possible implant-associated anaplastic large cell lymphoma, ultrasound is usually appropriate as the initial imaging. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Chetlen A, Niell BL, Brown A, et al. ACR Appropriateness Criteria® Breast Implant Evaluation: 2023 Update. J Am Coll Radiol. 2023. PMID: 38040459. doi:10.1016/j.jacr.2023.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。